Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.

Saved in:

Bibliographic Details
Title:	Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.
Authors:	Avraham M; Department of Cell and Developmental Biology, The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Sinkovits G; Department of Internal Medicine and Hematology and Research Group for Immunology and Hematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest, Hungary., Hurler L; Department of Internal Medicine and Hematology and Research Group for Immunology and Hematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest, Hungary., Prohászka Z; Department of Internal Medicine and Hematology and Research Group for Immunology and Hematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest, Hungary., Fishelson Z; Department of Cell and Developmental Biology, The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Source:	Frontiers in immunology [Front Immunol] 2024 Apr 23; Vol. 15, pp. 1337215. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2024.1337215